This web site is part of the Business Intelligence Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
XTL Biopharmaceuticals Ltd.
Drug Names(s): BC2125
Description: XTL-2125 is a small molecule non-nucleoside polymerase inhibitor that targets the RNA replication process.
Additional information available to subscribers only: